IRIDEX Corporation (IRIX)

NASDAQ: IRIX · Real-Time Price · USD
0.9610
-0.0192 (-1.96%)
Jun 5, 2025, 4:00 PM - Market closed
-1.96%
Market Cap 16.13M
Revenue (ttm) 48.80M
Net Income (ttm) -7.13M
Shares Out 16.79M
EPS (ttm) -0.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 74,060
Open 0.9862
Previous Close 0.9802
Day's Range 0.9600 - 1.0000
52-Week Range 0.7820 - 2.4780
Beta 0.61
Analysts n/a
Price Target n/a
Earnings Date May 13, 2025

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retino... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Feb 15, 1996
Employees 93
Stock Exchange NASDAQ
Ticker Symbol IRIX
Full Company Profile

Financial Performance

In 2024, IRIDEX's revenue was $48.67 million, a decrease of -6.17% compared to the previous year's $51.87 million. Losses were -$8.91 million, -6.90% less than in 2023.

Financial Statements

News

IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript

IRIDEX Corporation, Inc. (NASDAQ:IRIX) Q1 2025 Earnings Conference Call May 13, 2025 5:00 PM ET Company Participants Trip Taylor - IR Patrick Mercer - CEO, President & Director Romeo Dizon - CFO Conf...

22 days ago - Seeking Alpha

Iridex Reports First Quarter 2025 Financial Results

MOUNTAIN VIEW, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and proc...

23 days ago - GlobeNewsWire

IRIDEX Changes Course

IRIDEX's strategic review ended without a major asset sale, but a $10M investment from Novel Inspiration International offers growth potential and cash stability. Novel's investment values IRIDEX shar...

4 weeks ago - Seeking Alpha

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

MOUNTAIN VIEW, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr...

5 weeks ago - GlobeNewsWire

IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript)

IRIDEX Corporation (NASDAQ:IRIX) Strategic Vision Conference Call April 16, 2025 5:00 PM ET Company Participants Trip Taylor - Investor Relations Patrick Mercer - Chief Executive Officer Will Moore -...

7 weeks ago - Seeking Alpha

Iridex to Host Strategic Vision Call on April 16, 2025

MOUNTAIN VIEW, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr...

2 months ago - GlobeNewsWire

IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript

IRIDEX Corporation (NASDAQ:IRIX) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Company Participants Trip Taylor - Investor Relations Department Patrick Mercer - Chief Executive Officer R...

2 months ago - Seeking Alpha

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr...

2 months ago - GlobeNewsWire

Iridex Announces Strategic Investment in the Company

MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for ...

2 months ago - GlobeNewsWire

Iridex Comments on Recent Stock Price Volatility

MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for ...

2 months ago - GlobeNewsWire

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for ...

3 months ago - GlobeNewsWire

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for t...

6 months ago - GlobeNewsWire

Iridex Comments on Changing Glaucoma Reimbursement Landscape

MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro...

7 months ago - GlobeNewsWire

IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript

IRIDEX Corporation (NASDAQ:IRIX) Q3 2024 Earnings Call Transcript November 12, 2024 5:00 PM ET Company Participants Scott Shuda - Executive Chairman Patrick Mercer - CEO Fuad Ahmad - Interim CFO Oper...

7 months ago - Seeking Alpha

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro...

7 months ago - GlobeNewsWire

Iridex Appoints Patrick Mercer as Chief Executive Officer

MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro...

8 months ago - GlobeNewsWire

Iridex Frustrates, But Expect A Transaction By Year-End

IRIDEX has faced delays in selling its assets as part of a strategic review initiated a year ago, causing frustration among shareholders. Despite setbacks, the company remains committed to selling all...

10 months ago - Seeking Alpha

IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript

IRIDEX Corporation (NASDAQ:IRIX) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Philip Taylor – Investor Relations David Bruce – Chief Executive Officer Fuad Ahmad – ...

10 months ago - Seeking Alpha

IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript

IRIDEX Corporation (NASDAQ:IRIX) Q1 2024 Earnings Conference Call May 14, 2024 5:00 PM ET Company Participants Trip Taylor - Investor Relations David Bruce - Chief Executive Officer Fuad Ahmad - Inte...

1 year ago - Seeking Alpha

Iridex Reports First Quarter 2024 Financial Results

MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and proc...

1 year ago - GlobeNewsWire

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Iridex Corporation is undergoing a strategic review process to unlock shareholder value. The company is likely to sell its retina business line and potentially parse it out in more than one transactio...

1 year ago - Seeking Alpha

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr...

1 year ago - GlobeNewsWire

Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024

MOUNTAIN VIEW, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr...

1 year ago - GlobeNewsWire

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

MOUNTAIN VIEW, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today announced the first ...

1 year ago - GlobeNewsWire